ABA Life Secures $40M Investment from Admaius Capital to Scale HealthTech Platform

Mohamed Benouda, Founder & President of ABA Technology

Key Takeaways:

• Morocco-based ABA Life, the healthcare subsidiary of industrial IoT group ABA Technology, has executed a conditional $40 million investment agreement with private equity firm Admaius Capital Partners, pending clearance from Morocco's Competition Council.
• Founded five years ago, the company pairs proprietary software and clinical artificial intelligence via Mediot AI with physical medical devices, telemedicine infrastructure, and on-the-ground healthcare operations.
• ABA Life claims existing profitability, though specific revenue and EBITDA metrics remain undisclosed.
• The capital will fund sovereign clinical AI capabilities, domestic infrastructure deployment, and cross-border expansion.

 

How Much Funding Has ABA Life Secured from Admaius Capital Partners?

ABA Life, the healthcare arm of Moroccan technology group ABA Technology, has signed a US$40 million investment agreement with Admaius Capital Partners, marking a major step in the company's expansion and international growth strategy.

The transaction remains subject to customary closing conditions and clearance from the Competition Council of the Kingdom of Morocco. Once completed, the investment will provide capital to accelerate ABA Life's technology development, expand its healthcare operations and support its entry into international markets.

Founded five years ago, ABA Life has developed an integrated healthcare model combining artificial intelligence (AI), medical technology, telemedicine, connected health infrastructure and healthcare operations. The company says its model is already profitable, distinguishing it from early-stage healthtech businesses focused primarily on technology development.

The investment will support ABA Life's ambition to build an internationally competitive healthtech platform from Morocco.

How Will ABA Life Use the US$40M Investment?

ABA Life plans to direct the investment towards three strategic priorities, with a particular focus on AI-driven clinical innovation and scaling its healthcare infrastructure.

Strategic priority	Planned development
AI for Sovereign Health	Accelerate the programme through Mediot AI and develop clinical intelligence solutions
Technology deployment	Industrialise and deploy the group's healthcare technologies and services at scale
International expansion	Accelerate entry into international markets and establish ABA Life as a global healthtech player

A central component of the strategy is AI for Sovereign Health, which aims to develop clinical intelligence capabilities in Morocco and extend them to international markets through Mediot AI.

The programme reflects ABA Life's broader ambition to combine locally developed AI capabilities with medical innovation and operational expertise. Rather than operating solely as a software provider, the company intends to build a platform that connects technology directly with healthcare delivery.

Mohamed Benouda, Founder and Chairman of ABA Technology, said the investment marks a transition from establishing a profitable healthcare technology model to accelerating its scale and internationalisation.

What Makes ABA Life's HealthTech Business Model Different?

ABA Life has built an integrated healthcare model that brings together technology development, medical equipment, connected infrastructure and healthcare operations.

Its approach extends beyond digital health applications and telemedicine platforms. By combining proprietary technology with operational healthcare capabilities, the company aims to translate innovation into services that can be deployed at scale.

Its model includes five interconnected areas:

• Artificial intelligence: Developing AI-powered clinical intelligence solutions through initiatives such as Mediot AI.
• Medical technology: Integrating medical devices and technology into healthcare delivery.
• Telemedicine: Using digital consultations to broaden access to medical services.
• Connected health infrastructure: Linking healthcare facilities and services through technology.
• Healthcare operations: Supporting the practical delivery and management of healthcare programmes.

ABA Life has also implemented large-scale programmes, particularly through partnerships with public institutions and foundations. These initiatives have demonstrated the company's ability to apply technology to healthcare access challenges.

The company says it has achieved profitability within its first five years, although it has not disclosed revenue, earnings or other financial performance figures in the announcement.

Why Did Admaius Capital Partners Invest in ABA Life?

Admaius Capital Partners cited ABA Life's integrated business model, technology capabilities and potential for international expansion as key reasons for the investment.

Selim Ettriqui, Head of Morocco and West Africa at Admaius Capital Partners, highlighted the company's combination of medical devices, connected infrastructure, healthcare operations and proprietary technology developed in Morocco.

Marlon Chigwende, Managing Partner at Admaius Capital Partners, added that ABA Life demonstrated the qualities the firm seeks in its investments: an ambitious entrepreneurial team, a proven business model, strong technology foundations and significant potential to scale.

The investment also positions Admaius as a partner in ABA Life's next phase of growth, supporting its ambition to become an international healthtech reference.

Can ABA Life Become Morocco's Next HealthTech Unicorn?

ABA Life's ambition is to build a global healthtech company from Morocco, with the long-term goal of becoming one of the Kingdom's next technology unicorns.

The US$40 million agreement provides a foundation for that ambition, although the transaction remains conditional and the company has not disclosed a valuation or a timeline for reaching unicorn status.

Its strategy centres on combining three capabilities:

• Locally developed technology: Building AI and clinical intelligence solutions in Morocco.
• Integrated healthcare delivery: Connecting medical technology and digital tools with operational healthcare services.
• International scalability: Deploying its platform and services in additional markets.

The investment also highlights the potential for Moroccan technology companies to develop solutions for international markets while retaining their technology development and operational foundations at home.

If ABA Life can successfully scale its integrated model beyond Morocco, it could strengthen the country's position as a source of healthtech innovation and demonstrate how technology-led healthcare operators can expand across borders.